SMARCB1 NEGATIVE

Clinical trials for SMARCB1 NEGATIVE explained in plain language.

Never miss a new study

Get alerted when new SMARCB1 NEGATIVE trials appear

Sign up with your email to follow new studies for SMARCB1 NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo tested for aggressive, rare kidney cancer

Disease control Ongoing

This study is testing whether adding a new drug called ixazomib to two standard chemotherapy drugs works better for controlling an aggressive type of kidney cancer that has spread. It is for patients aged 12 and older whose cancer has progressed after other treatments and who hav…

Matched conditions: SMARCB1 NEGATIVE

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

SMARCB1 NEGATIVE

Get alerted when new SMARCB1 NEGATIVE trials appear

New drug combo tested for aggressive, rare kidney cancer